SCHEMBL3264183

SCHEMBL3264183

CC(C)c1n[nH]c2c(NCc3ccccc3O)ncnc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 9/20 0.67
CDK1 P06493 9/20 0.67
CCNB1 P14635 9/20 0.67
CCNB3 Q8WWL7 9/20 0.67
CASP6 P55212 1/20 0.41
CDK2 P24941 3/20 0.40
CCNE1 P24864 2/20 0.40
CDK5 Q00535 2/20 0.40
CCNT1 O60563 1/20 0.40
CDK9 P50750 1/20 0.40
CDK5R1 Q15078 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
EGFR P00533 1/20 0.39
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3238638 0.86 CCNB2 (0.67) CCNB2CDK1CCNB1CCNB3CDK2
SCHEMBL3239170 0.84 CDK1 (0.63) CCNB2CDK1CCNB1CCNB3CDK2
SCHEMBL3241707 0.82 CCNB2 (0.65) CCNB2CDK1CCNB1CCNB3CDK2
SCHEMBL3235858 0.81 CCNB2 (0.67) CCNB2CDK1CCNB1CCNB3CDK2
SCHEMBL3264180 0.80 CCNB2 (1.00) CCNB2CDK1CCNB1CCNB3CASP6
SCHEMBL3239140 0.78 CCNB2 (0.68) CCNB2CDK1CCNB1CCNB3MEN1
SCHEMBL3242569 0.77 CCNB2 (0.70) CCNB2CDK1CCNB1CCNB3MAPT
SCHEMBL18227149 0.76 CCNE1 (0.69) CDK1CCNB1CDK2CCNE1CDK5
SCHEMBL5466498 0.75 CDK1 (0.66) CCNB2CDK1CCNB1CCNB3MEN1
SCHEMBL3238350 0.73 CDK1 (0.64) CCNB2CDK1CCNB1CCNB3CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1475094-B1 Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use USTAV EX BOTAN AKADEMIE VED CE (CZ) 2010-07-28 EP disclosed
US-20070167466-A1 \"Pyrazolo [4,3-d]pyrimidines, processes for their preparation and methods of use\ UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2007-07-19 US disclosed
EP-1475094-A1 Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use Ustav Experimentalni Botaniky Akademie ved Ceské Republiky (CZ) 2004-11-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167466-A1 \"Pyrazolo [4,3-d]pyrimidines, processes for their preparation and methods of use\ CBR3, PYM1, PNPO CCNB2 1222/4885CDK1 1025/4885CCNB1 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.